• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Functional analysis of a novel E3 ubiquitin ligase, c-MIR

Research Project

Project/Area Number 16590405
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Immunology
Research InstitutionRIKEN

Principal Investigator

ISHICO Satoshi  RIKEN, Infectious Immunity Team, Team Leader, 感染免疫応答研究チーム, チームリーダー (10273781)

Project Period (FY) 2004 – 2005
Keywordsubiquitin / antigen presentation / ubiquitin ligase / MHC Class II / endocytosis / B7-2 / transgenic mouse / immunosuppressor
Research Abstract

We previously reported a novel E3 ubiquitin ligase (E3)^4, designated as c-MIR, which targets B7-2 to lysosomal degradation and down-regulates the B7-2 surface expression through ubiquitination of its cytoplasmic tail. B7-2 is well known as a co-stimulatory molecule for antigen presentation, suggesting that the manipulation of c-MIR expression modulates immune responses in vivo. To examine this hypothesis, we generated genetically modified mice in which c-MIR was expressed under an invariant chain (li) promoter. Dendritic cells (DCs) derived from genetically engineered mice showed low ability to present antigens. In addition, these mice showed resistance to the onset of experimental autoimmune encephalomyelitis (EAE) and an impaired development of CD4 T cells in the thymus and the periphery. These findings led us to conclude that MHC class II (MHC II) is an additional target for c-MIR. Indeed, forced expression of c-MIR in several B cell lines down-regulated the surface expression of MHC II, and downregulation was found to depend on the presence of a single lysine residue in the cytoplasmic tail of the I-A β chain. In a reconstitution system using 293T cells, we found that the lysine residue at position 225 in the I-A β chain was ubiquitinated by c-MIR. To our knowledge, c-MIR is the first example of an E3 that is capable of inhibiting MHC II expression. Our findings suggest that c-MIR might potently regulate immune responses in vivo.

  • Research Products

    (13 results)

All 2006 2005

All Journal Article (12 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] A novel family of membrane-bound E3 ubiquitin ligases2006

    • Author(s)
      Ohmura-Hoshino, M., Goto, E., Matsuki, Y., Aoki, M., Mito, M., Uematsu, M., Hotta, H., Ishido, S.
    • Journal Title

      The Journal of Biochemistry (In press)

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Inhibition of MHC class II expression and immune responses by c-MIR12006

    • Author(s)
      Ohmura-Hoshino, M., Matsuki, Y., Aoki, M., Goto, E., Mito, M., M.Uematsu, Kakiuchi, T., Hotta, H., Ishido, S.
    • Journal Title

      The Journal of Immunology (In press)

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] 膜結合型新規E3ユビキチンリガーゼファミリー2006

    • Author(s)
      星野真理, 後藤栄治, 石戸聡
    • Journal Title

      実験医学 (In press)

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3.2006

    • Author(s)
      Tanaka M, Nagano-Fujii M, Deng L, Ishido S, Sada K, Hotta H.
    • Journal Title

      Biochemical and Biophysical Research Communications 340(3)

      Pages: 792-799

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] ユビキチンとウイルス感染2006

    • Author(s)
      石戸聡
    • Journal Title

      医学のあゆみ 別冊

      Pages: 108-113

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] A novel family of membrane-bound E3 ubiquitin ligases2006

    • Author(s)
      Ohmura-Hoshino M., Goto, E., Matsuki, Y., Aoki, M., Mito, M., Uematsu, M., Hotta, H., Ishido, S.
    • Journal Title

      The Journal of Biochemistry (in Press)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Inhibition of MHC class II expression and immune responses by c-MIR12006

    • Author(s)
      Ohmura-Hoshino, M., Matsuki, Y., Aoki, M., Goto, E., Mito, M., M.Uematsu, Kakiuchi, T., Hotta H., Ishido S.
    • Journal Title

      The Journal of Immunology (in Press)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Makuketugogata sinki E3 yubikitinrigahzefamily2006

    • Author(s)
      Ohmura-Hoshino M., Goto, E., Ishido, S.
    • Journal Title

      Jikken Igaku (in Press)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3.2006

    • Author(s)
      Tanaka M, Nagano-Fujii M, Deng L, Ishido S, Sada K, Hotta H.
    • Journal Title

      Biochemical and Biophysical Research Communicaitons 340(3)

      Pages: 792-799

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] yubikitin to uirusukansen2006

    • Author(s)
      Ishido, S.
    • Journal Title

      Igaku no Ayumi separate vol.

      Pages: 108-113

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] KSHV ni taisuru Mennekiouto2006

    • Author(s)
      Ishido, S.
    • Journal Title

      Nihon Rinsyo

      Pages: 568-575

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] KSHVに対する免疫応答2005

    • Author(s)
      石戸聡
    • Journal Title

      日本臨牀

      Pages: 568-575

    • Description
      「研究成果報告書概要(和文)」より
  • [Patent(Industrial Property Rights)] ヘルペスウイルス免疫回避分子を機能評価できる細胞株2005

    • Inventor(s)
      石戸聡
    • Industrial Property Rights Holder
      独立行政法人理化学研究所
    • Industrial Property Number
      2005-287308
    • Filing Date
      2005-10-20
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2007-12-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi